r-HuEPO对癫癎持续状态大鼠血清NSE S-100β蛋白和MBP表达的影响

蒋春明; 杜建民; 刘占利; 陈丽琼; 冯梅; 杨一华; 王洁华; 黄先玫

PDF(902 KB)

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (1) : 50-52.

论著·实验研究

r-HuEPO对癫癎持续状态大鼠血清NSE S-100β蛋白和MBP表达的影响

蒋春明，杜建民，刘占利，陈丽琼，冯梅，杨一华，王洁华，黄先玫

作者信息 +

Effects of recombinant human erythropoietin on serum levels of neuron-specific enolase, S-100β protein and myelin basic protein in rats following status epilepticus

JIANG Chun-Ming, DU Jian-Min, LIU Zhan-Li, CHEN Li-Qiong, FENG Mei, YANG Yi-Hua, WANG Jie-Hua, HUANG Xian-Mei

Author information +

文章历史 +

摘要

目的：通过观察重组人促红细胞生成素(r-HuEPO)对幼年大鼠癫癎持续状态（SE）后24 h血清神经元特异性烯醇化酶(NSE)、S-100β蛋白和髓鞘碱性蛋白(MBP)表达的影响，以观察其在癫癎性脑损伤中的可能作用。方法：40只19～21日龄Sprague-Dawley雄性大鼠随机分为正常对照组(CON组)、SE组、r-HuEPO预处理+SE组(SE-EPO组)、r-HuEPO组(EPO组)（n=10），采用氯化锂匹鲁卡品点燃制成SE模型。SE-EPO组和EPO组在制模前4 h腹腔注射r-HuEPO 500 IU/kg。在SE后24 h测定血清中NSE、S-100β蛋白、MBP含量的变化。结果：与CON、EPO组相比，SE组血清NSE、S-100β蛋白、MBP浓度均显著升高（P＜0.05）；与SE组比较，SE-EPO组NSE、S-100β蛋白、MBP均显著下降（P＜0.05）。结论：r-HuEPO可降低癫癎后神经组织损伤指标表达，对癫癎性脑损伤可能具有早期保护作用。

Abstract

OBJECTIVE: This study examined the effect of recombinant human erythropoietin (r-HuEPO) on the serum levels of neuron-specific enolase (NSE), S-100β protein and myelin basic protein (MBP) in young rats 24 hrs after lithium-pilocarpine-induced status epilepticus (SE) in order to study the potential role of r-HuEPO in epileptic brain damage. METHODS: Forty 19-21-day-old male Sprague-Dawley (SD) rats were randomly divided into four groups (n=10): normal control group, SE, r-HuEPO pretreated-SE and r-HuEPO. SE was induced by lithium-pilocarpine. R-HuEPO (500 IU/kg) was intraperitoneally injected in the r-HuEPO pretreated-SE and r-HuEPO groups 4 hrs before SE. Serum levels of NSE, S-100β and MBP were determined 24 hrs after the SE event. RESULTS: Serum levels of NSE, S-100β and MBP in the SE group increased significantly compared with those in the normal control and the r-HuEPO groups (P＜0.05). The r-HuEPO pretreated-SE group showed significantly decreased serum levels of NSE, S-100β and MBP compared with the SE group (P＜0.05). CONCLUSIONS: r-HuEPO may reduce the expression of NSE, S-100β and MBP and thus might provide an early protective effect against epileptic brain injury.

导出引用

蒋春明, 杜建民, 刘占利, 陈丽琼, 冯梅, 杨一华, 王洁华, 黄先玫. r-HuEPO对癫癎持续状态大鼠血清NSE S-100β蛋白和MBP表达的影响[J]. 中国当代儿科杂志. 2011, 13(1): 50-52

JIANG Chun-Ming, DU Jian-Min, LIU Zhan-Li, CHEN Li-Qiong, FENG Mei, YANG Yi-Hua, WANG Jie-Hua, HUANG Xian-Mei. Effects of recombinant human erythropoietin on serum levels of neuron-specific enolase, S-100β protein and myelin basic protein in rats following status epilepticus[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(1): 50-52

中图分类号： R-33

参考文献

［1］Kondratyev A, Gale K. Temporal and spatial patterns of DNA fragmentation following focally or systemically-evoked status epilepticus in rats［J］. Neurosci Lett, 2001,310(1):13-16. ［2］Covolan L, Smith RL, Mello LE. Ultrastructural identification of dentate granule cell death from pilocarpine-induced seizures［J］. Epilepsy Res, 2000, 41(1): 9-21. ［3］Buemi M, Donato V, Bolignano D. Erythropoientin: pleiotropic actions［J］. Recenti Prog Med, 2010, 101(6): 253-267. ［4］Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes［J］.J Biol Chem, 1994, 269(30): 19488-19493. ［5］Li Y, Lu Z, Keogh CL, Yu SP, Wei L. Erythropoietininduced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice［J］. J Cereb Blood Flow Metab, 2007, 27(5): 1043-1054. ［6］王岩松,姚猛,董大明,孙宗毅.促红细胞生成素（EPO）的神经保护作用［J］.中华神经外科杂志, 2005, 21(7): 445-448. ［7］卢俊杰,蒋犁,朱欢,韩树萍,余章斌. 脑源性促红细胞生成素在新生鼠脑缺氧缺血后海马的表达变化［J］. 临床儿科杂志, 2009, 27(6): 576-579. ［8］蒋春明, 张春霞, 林忠东, 叶秀云, 焦颖, 李伟. 促红细胞生成素和神经元特异性烯醇化酶在热性惊厥中的变化及意义［J］. 医学研究杂志, 2008,37(5): 73-75. ［9］胡越,蒋莉. 控制氯化锂-匹罗卡品诱发惊厥持续状态发作的实验研究［J］. 儿科药学杂志, 2003, 9(4): 5-8. ［10］Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure［J］. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281-294. ［11］Chu K, Jung KH, Lee ST, Kim JH, Kang KM, Kim HK, et al. Erythropoietin reduces epileptogenic processes following status epilepticus［J］. Epilepsia, 2008, 49(10): 1723-1732. ［12］李光乾, 林忠东, 叶秀云,施旭来, 焦颖,胡鸿文. 热性惊厥患儿血清和脑脊液神经特异性烯醇化酶、S-100β蛋白及髓鞘碱性蛋白的测定［J］. 中华神经科杂志, 2004, 37(4): 376-378. ［13］李光乾,林忠东,焦颖,施旭来,叶秀云,胡鸿文. 癫癎发作后患儿血清和脑脊液中神经元特异性烯醇化酶、S-100β蛋白及髓鞘碱性蛋白的变化［J］.中国当代儿科杂志, 2004, 6(6):500-503. ［14］Li Y, Lu ZY, Ogle M, Wei L. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice［J］. Neurochem Res, 2007, 32(12): 2132-2141. ［15］Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice［J］. Neurobiol Dis, 2006,24(2):357-366. ［16］Kondo A, Shingo T, Yasuhara T, Kuramoto S, Kameda M, Kikuchi Y, et al. Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats［J］. Brain Res, 2009, 3(1296): 127-136. ［17］Jun Y, JiangTao X, YuanGui H, YongBin S, Jun Z, XiaoJun M, et al. Erythropoietin pre-treatment prevents cognitive impairments following status epilepticus in rats［J］. Brain Res, 2009, 1282: 57-66.